Sleep Aid +
Natural health product licensed in Canada
- Licence holder
- Red Maple Bio Inc.
- NPN or DIN-HM
- 80090850
- Status
- Active licence
- Licence date
- 22 February 2019
- Revision date
- 18 October 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Valeriana officinalis L.: L'absence de valépotriates doit être prouvée par des rapports d'analyse. L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-5-hydroxytryptophane Source : Griffonia simplicifolia, graine | 70 milligramme | Not calculated |
| N-[2-(5-méthoxy-1H-indol-3-yl)éthyl]acétamide Source : Mélatonine | 4.9 milligramme | Not calculated |
| Passiflora incarnata Source : Plante entière Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 300 milligramme | 75 milligramme | Not calculated |
| Valeriana officinalis Source : Rhizome Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 300 milligramme | 60 milligramme | Not calculated |
| L-théanine Source : Camellia sinensis - feuille | 200 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Gélatine, Dioxyde de silicium, Cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 day |
Uses authorised in Canada
Helps to reduce the time it takes to fall asleep in people who fall asleep slowly and in those with delayed sleep phase disorder. Helps increase total sleep time in people suffering from sleep restriction or altered sleep schedule.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use If you are pregnant or breastfeeding or if you have scleroderma or if you have a known allergy to plants of the sunflower family (Asteraceae/Compositae) .
Source
Official Health Canada record, licence 80090850
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging